Ex vivo analysis showed significantly higher percentages of CCR9+ and integrin α4+β7+ cells within CD161+ Tconv (Figure 7A) and CD161+ Treg (Figure 7B) compared to their CD161− counterparts in blood of JIA patients. The gene discussed is CCR9; the disease is juvenile idiopathic arthritis.